Chemours Company (the) · NYSE:CC

Chemours Company (the) — Q4 2024 Earnings Presentation

25 slides from Chemours Company (the)'s earnings presentation, Feb 18, 2025

  1. Slide 1: Fourth Quarter and Full Year 2024 Earnings Presentation

    Fourth Quarter and Full Year 2024 Earnings Presentation February 18, 2025

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current exp

  3. Slide 3: Fourth Quarter and Full Year 2024 Highlights

    Fourth Quarter and Full Year 2024 Highlights Generated $1.4B in Net Sales and $179M in Adjusted EBITDA in 4Q24, exceeding Adjusted EBITDA expectations across all business Achieved 23% and 14% YoY Net Sales growth in 4Q24 and FY24, respectively, for Opteon Refrigerants in TSS, reflecting continued st

  4. Slide 4: Fourth Quarter 2024 Financial Summary

    Fourth Quarter 2024 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 4Q24 4Q23 Y-o-Y ∆ 3Q24 Q-o-Q ∆ Net Sales $1,359 $1,368 ($9) $1,508 ($149) Net (Loss) / Income 1 ($8) ($18) $10 ($27) $19 Adj. Net Income 2 $16 $46 ($30) $61 ($45) EPS 3 ($0.05) ($0.12) $0.07 ($0.

  5. Slide 5: Full Year 2024 Financial Summary

    Full Year 2024 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) FY24 FY23 Y-o-Y ∆ Net Sales $5,782 $6,078 ($296) Net Income / (Loss) 1,5 $86 ($238) $324 Adj. Net Income 2,5 $182 $425 ($243) EPS 3 $0.57 ($1.60) $2.17 Adj. EPS 2,3 $1.21 $2.82 ($1.61) Adj. EBITDA 2,4

  6. Slide 6: Adjusted EBITDA Bridge: 4Q24 versus 4Q23

    Adjusted EBITDA Bridge: 4Q24 versus 4Q23 ($ in millions) ($37) $5 $10 $25 $176 $179 4Q23 Price Volume Cost/Other Currency 4Q24 Price Declines:($37) million due to lower pricing across all businesses Volume Impacts: $10 million primarily driven by increased volumes in TSS Cost/Other Impacts: $25 mill

  7. Slide 7: Adjusted EBITDA Bridge: FY24 versus FY23

    Adjusted EBITDA Bridge: FY24 versus FY23 ($ in millions) ($261) ($20) ($12) ($3) $68 $1,014 $786 FY23 Price Volume Cost/Other Currency Portfolio FY24 Price Declines:($261) million due to lower pricing across all businesses Cost/Other Impacts: $68 million primarily driven by cost savings realized thr

  8. Slide 8: Quarterly Segment Summary

    Quarterly Segment Summary7 ($ in millions unless otherwise noted) Net Sales TSS TT APM $322 $380 $390 $606 $651 $632 $386 $326 $324 4Q22 4Q23 4Q24 4Q22 4Q23 4Q24 4Q22 4Q23 4Q24 Adjusted EBITDA and Margin (%) TSS TT APM $54 $124 $123 $42 $64 $77 $61 $40 $48 4Q22 4Q23 4Q24 4Q22 4Q23 4Q24 4Q22 4Q23 4Q2

  9. Slide 9: Full Year Segment Summary

    Full Year Segment Summary7 ($ in millions unless otherwise noted) Net Sales TSS TT APM $1,702 $1,851 $1,830 $3,380 $2,680 $2,572 $1,633 $1,462 $1,326 FY22 FY23 FY24 FY22 FY23 FY24 FY22 FY23 FY24 Adjusted EBITDA and Margin (%) TSS TT APM $603 $685 $576 $601 $290 $312 $367 $273 $161 FY22 FY23 FY24 FY2

  10. Slide 10: Liquidity Position as of December 31, 2024

    Liquidity Position as of December 31, 2024 ($ in millions unless otherwise noted) Total Liquidity 11 $1.4B Gross Debt $4.2B Net Debt 12 $3.4B TTM Net Leverage 13 4.4x $763 $666 $138 $104 $50 Restricted $70 Restricted ($109) ($36) $596 $713 Unrestricted Unrestricted 8 9 10 8 3Q24 Cash Balance Operati

  11. Slide 11: First Quarter 2025 Guidance

    First Quarter 2025 Guidance Sequential Business Outlook:  TSS o Net Sales: Expected to increase sequentially driven by double-digit growth in Opteon Refrigerants, partially offset by a decrease in Freon Refrigerants in connection with the ongoing transitions under the U.S. AIM Act and EU F-Gas regu

  12. Slide 12: Full Year 2025 Outlook

    Full Year 2025 Outlook14 Key Business Factors and Assumptions  High end of Adjusted EBITDA range anticipates a more favorable macroeconomic environment for TT and APM, Adjusted TSS pricing action success paired with input cost EBITDA $825M - $975M  moderation, and Freon pricing strength Low end of

  13. Slide 13: Our Corporate Strategy: Pathway to Thrive

    Our Corporate Strategy: “Pathway to Thrive” Pillars for Success PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long Term  Manufacturing excellence as  Investing smartly in selected  Holistic portfolio analysis  Measurable progress on a basis for s

  14. Slide 14: Our Corporate Strategy: Significant Progress Achieved to Date

    Our Corporate Strategy: “Pathway to Thrive” Significant Progress Achieved to Date PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long Term  Continued strong execution of  Achieved double-digit Y-o-Y  Initiated strategic review of  Continued focus

  15. Slide 15: Appendix

    Appendix

  16. Slide 16: 2024 Disruption and Investment Costs

    2024 Disruption and Investment Costs ($ in millions unless otherwise noted) Cost Type & Description 15,16 Full Year 2024 Titanium Technologies $26 Impacts from Q2 Altamira unplanned shut down Thermal and Specialized Solutions SG&A and R&D Investments to Support Innovation (2P50 & NGR) – expected to

  17. Slide 17: TSS Segment Net Sales and Adjusted EBITDA

    TSS Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) % of total Net Sales $380 $390 FP&O FP&O 25% ($16) $26 22% Freon Freon Refrigerants Refrigerants 32% 37% Opteon Opteon Refrigerants Refrigerants $124 $123 38% 46% 4Q23 Price/Currency Volume 4Q24 4Q23 Price/Currency

  18. Slide 18: TT Segment Net Sales and Adjusted EBITDA

    TT Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) $651 $632 ($11) ($8) $64 $77 4Q23 Price/Currency Volume Cost/Other 4Q24 4Q23 Price/Currency Volume 4Q24 Net Sales: The decrease was primarily driven by a 2% decrease in pricing and a 1% decrease in volume, while cur

  19. Slide 19: APM Segment Net Sales and Adjusted EBITDA

    APM Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) % of total Net Sales $326 $324 Performance Performance ($8) $6 Solutions Solutions 41% 41% Advanced Advanced Materials Materials 59% 59% $48 $40 4Q23 Price/Currency Volume 4Q24 4Q23 Price/Currency Volume Cost/Other

  20. Slide 20: Segment Net Sales (Unaudited)

    Segment Net Sales (Unaudited)1 ($ in millions) 2022 2023 2024 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Net sales by product group and segment OpteonTM refrigerants $ 143 $ 182 $ 150 $ 122 $ 195 $ 200 $ 170 $ 145 $ 200 $ 227 $ 205 $ 178 FreonTM refrigerants 197 241 177 135 185 226 170 141 173 173 146 124

  21. Slide 21: Segment Net Sales and Adjusted EBITDA (Unaudited)

    Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) Three Months Ended Three Months Year Ended December 31, September 30, December 31, 2024 2023 2024 2024 2023 SEGMENT NET SALES (1) Thermal & Specialized Solutions $ 390 $ 380 $ 468 $ 1,830 $ 1,851 Titanium Technologies 632 651 672 2,57

  22. Slide 22: GAAP Net (Loss) Income to Adjusted Net Income and Adjusted EBITDA (Page 1/2)

    GAAP Net (Loss) Income Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Year Ended December 31, September 30,

  23. Slide 23: GAAP Net (Loss) Income to Adjusted Net Income and Adjusted EBITDA (Page 2/2)

    GAAP Net (Loss) Income Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 2/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Year Ended December 31, September 30,

  24. Slide 24: 2025 Estimated GAAP Net Income to Estimated Adjusted EBITDA

    2025 Estimated GAAP Net Income Attributable to Chemours to Estimated Adjusted Net Income, Estimated Adjusted EBITDA(*) ($ in millions) (Estimated) Year Ending December 31, 2025 Low High Net income attributable to Chemours $ 200 $ 315 Restructuring, transaction, and other costs, net (1) — — Adjusted

  25. Slide 25: ® 2025 CHEMOURS. ALL RIGHT RESERVED

    ® 2025 CHEMOURS. ALL RIGHT RESERVED

Chemours Company (The) — Q4 2024 Earnings Presentation on 6ix